FMP
Enter
API Tools
Extras
Forte Biosciences, Inc.
FBRX
NASDAQ
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
19.34 USD
0.68 (3.52%)
About
ceo
Dr. Paul A. Wagner Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.fortebiorx.comexchange
NASDAQ
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
CIK
0001419041
ISIN
US34962G1094
CUSIP
34962G109
Address
3060 Pegasus Park Drive
Phone
310 618 6994
Country
US
Employee
11
IPO Date
Apr 13, 2017
Key Executives
